Showing results (91-100 of 118) with videos related to
Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2018
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant MesotheliomaVasiliki Panou, Meghana Gadiraju, Arthur Wolin, et al.Journal for Immunotherapy of Cancer|May 31, 2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesotheliomaRamaswamy Govindan, Charu Aggarwal, Scott J Antonia, et al.Nature Cancer|November 28, 2022
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockadeLiam F Spurr, Carlos A Martinez, Wenjun Kang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2018
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid TumorsJason J Luke, Jeffrey M Lemons, Theodore G Karrison, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I TrialJason J Luke, Benjamin E Onderdonk, Sandeep R Bhave, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2013
Small cell lung cancerGregory P Kalemkerian, Wallace Akerley, Paul Bogner, et al.The Lancet. Oncology|November 14, 2017
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trialHeather A Wakelee, Suzanne E Dahlberg, Steven M Keller, et al.Neuro-Oncology Advances|February 23, 2023
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastomaBenedito A Carneiro, Kyriakos P Papadopoulos, John H Strickler, et al.Pageof 12